Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Gynecologic Oncology
|
January 24, 2025
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258
Aine Clements, Danielle Enserro, Kyle C Strickland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 25, 2024
Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial
Ann H Klopp, Danielle Enserro, Matthew Powell, et al.
Ejhaem
|
May 1, 2025
Belantamab Mafodotin Monotherapy for Multiply-Relapsed Myeloma: A Retrospective Study From the United Kingdom and the Republic of Ireland
Edmund C R Watson, Faouzi Djebbari, Fotios Panitsas, et al.
The Journal of Clinical Investigation
|
May 20, 2025
Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer
Angela Schab, Amanda Compadre, Rebecca Drexler, et al.
Biorxiv : the Preprint Server for Biology
|
December 9, 2024
Replication stress marker phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer
Angela Schab, Amanda Compadre, Rikki Drexler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2024
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005
Jung-Min Lee, Mark F Brady, Austin Miller, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 19, 2025
Multi-center, international endometrial cancer consortium highlights
Luigi De Vitis, Anna Giudici, Vincenzo Tarantino, et al.
Biorxiv : the Preprint Server for Biology
|
August 13, 2025
Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanisms
Elena Lomonosova, Megan Loeb, Kevin Rodriguez, et al.
JAMA
|
September 3, 2020
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
Derek C Angus, Lennie Derde, Farah Al-Beidh, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Gynecologic Oncology
|
January 24, 2025
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258
Aine Clements, Danielle Enserro, Kyle C Strickland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 25, 2024
Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial
Ann H Klopp, Danielle Enserro, Matthew Powell, et al.
Ejhaem
|
May 1, 2025
Belantamab Mafodotin Monotherapy for Multiply-Relapsed Myeloma: A Retrospective Study From the United Kingdom and the Republic of Ireland
Edmund C R Watson, Faouzi Djebbari, Fotios Panitsas, et al.
The Journal of Clinical Investigation
|
May 20, 2025
Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer
Angela Schab, Amanda Compadre, Rebecca Drexler, et al.
Biorxiv : the Preprint Server for Biology
|
December 9, 2024
Replication stress marker phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer
Angela Schab, Amanda Compadre, Rikki Drexler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2024
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005
Jung-Min Lee, Mark F Brady, Austin Miller, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 19, 2025
Multi-center, international endometrial cancer consortium highlights
Luigi De Vitis, Anna Giudici, Vincenzo Tarantino, et al.
Biorxiv : the Preprint Server for Biology
|
August 13, 2025
Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanisms
Elena Lomonosova, Megan Loeb, Kevin Rodriguez, et al.
JAMA
|
September 3, 2020
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
Derek C Angus, Lennie Derde, Farah Al-Beidh, et al.
Page
of 6